JO
OLMA icon

John Overdeck’s Olema Pharmaceuticals OLMA Stock Holding History

John Overdeck’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2M Sell
1,131,434
-37,987
-3% -$509K 0.01% 1269
2026
Q1 		$17.4M Buy
1,169,421
+775,763
+197% +$17.3M 0.01% 1028
2025
Q4 		$9.84M Buy
393,658
+284,132
+259% +$5.06M 0.01% 1134
2025
Q3 		$1.07M Buy
109,526
+17,025
+18% +$102K ﹤0.01% 2528
2025
Q2 		$394K Buy
92,501
+29,575
+47% +$132K ﹤0.01% 2679
2025
Q1 		$237K Sell
62,926
-9,951
-14% -$50K ﹤0.01% 2806
2024
Q4 		$425K Sell
72,877
-27,170
-27% -$271K ﹤0.01% 2603
2024
Q3 		$1.19M Sell
100,047
-82,073
-45% -$1.05M ﹤0.01% 2020
2024
Q2 		$1.97M Buy
182,120
+86,306
+90% +$936K ﹤0.01% 1559
2024
Q1 		$1.08M Sell
95,814
-69,895
-42% -$902K ﹤0.01% 1912
2023
Q4 		$2.32M Buy
165,709
+33,867
+26% +$455K 0.01% 1415
2023
Q3 		$1.63M Sell
131,842
-5,862
-4% -$59.8K ﹤0.01% 1568
2023
Q2 		$1.24M Sell
137,704
-23,729
-15% -$143K ﹤0.01% 1826
2023
Q1 		$560K Sell
161,433
-22,839
-12% -$93.2K ﹤0.01% 2152
2022
Q4 		$451K Sell
184,272
-107,698
-37% -$314K ﹤0.01% 2062
2022
Q3 		$806K Sell
291,970
-25,186
-8% -$107K ﹤0.01% 1557
2022
Q2 		$1.29M Sell
317,156
-277,187
-47% -$879K ﹤0.01% 1421
2022
Q1 		$2.53M Sell
594,343
-29,957
-5% -$165K 0.01% 1233
2021
Q4 		$5.84M Buy
624,300
+524,800
+527% +$10.9M 0.01% 1104
2021
Q3 		$2.74M Buy
+99,500
New +$2.69M 0.01% 1689

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

John Overdeck's OLMA Position: Q2 2026 in Review

John Overdeck reduced its Olema Pharmaceuticals (OLMA) stake by 3.2% in Q2 2026, selling an estimated $509K and leaving 1,131,434 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #1269.

John Overdeck first reported a position in OLMA in Q3 2021 and has held it in 20 quarters since. The position peaked at $17.4M in Q1 2026. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • John Overdeck held 1,131,434 shares of Olema Pharmaceuticals worth $14.2M as of Q2 2026.
  • John Overdeck sold 37,987 Olema Pharmaceuticals shares in Q2 2026, an estimated $509K.
  • Olema Pharmaceuticals made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1269 holding.
  • John Overdeck first reported a position in Olema Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • John Overdeck's Olema Pharmaceuticals position peaked at $17.4M in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.